PHOENIX Pharmahandel GmbH & Co KG Sustainability Profile
PHOENIX Pharmahandel GmbH & Co KG, a leading pharmaceutical wholesaler, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a key player in the healthcare sector, focusing on the distribution of pharmaceuticals, medical products, and healthcare services. With a commitment to quality and efficiency, PHOENIX offers a diverse range of services, including logistics solutions and digital healthcare innovations. Its unique approach to supply chain management ensures that healthcare providers receive timely access to essential medications and products. Recognised for its robust market position, PHOENIX Pharmahandel has achieved significant milestones, including numerous awards for excellence in service delivery. The company continues to enhance its reputation as a trusted partner in the pharmaceutical industry, dedicated to improving patient care across its operational regions.
DitchCarbon Score
How does PHOENIX Pharmahandel GmbH & Co KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PHOENIX Pharmahandel GmbH & Co KG's score of 52 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PHOENIX Pharmahandel GmbH & Co KG currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures. The company is a current subsidiary of PHOENIX Pharmahandel SE, which may influence its climate commitments and performance metrics. Despite the lack of specific emissions data, PHOENIX Pharmahandel GmbH & Co KG is part of a broader corporate family that may have established climate initiatives. However, there are no documented reduction targets or climate pledges available for this entity at this time. As a subsidiary, it is important to note that any climate commitments or emissions data may be inherited from its parent company, PHOENIX Pharmahandel SE. This relationship could potentially provide a framework for future sustainability efforts, but specific details on emissions or reduction initiatives remain unspecified. In summary, while PHOENIX Pharmahandel GmbH & Co KG is positioned within a corporate structure that may prioritise climate action, concrete emissions data and reduction targets are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 20,501,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,693,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 140,907,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is PHOENIX Pharmahandel GmbH & Co KG's Industry?
How Carbon Intensive is PHOENIX Pharmahandel GmbH & Co KG's Location?
PHOENIX Pharmahandel GmbH & Co KG's Scope 3 Categories Breakdown
PHOENIX Pharmahandel GmbH & Co KG's Scope 3 emissions, which decreased by 3% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
PHOENIX Pharmahandel GmbH & Co KG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PHOENIX Pharmahandel GmbH & Co KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
